Page last updated: 2024-08-17

physostigmine and Hyperglycemia

physostigmine has been researched along with Hyperglycemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Garcia, CC; Hognason, K; McArdle, JJ; Potian, JG; Routh, VH; Souayah, N; Sultatos, LG; Thyagarajan, B	1

Other Studies

1 other study(ies) available for physostigmine and Hyperglycemia

Article	Year
Acetylcholinesterase deficiency contributes to neuromuscular junction dysfunction in type 1 diabetic neuropathy. American journal of physiology. Endocrinology and metabolism, 2012, Aug-15, Volume: 303, Issue:4 Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; GPI-Linked Proteins; Hyperglycemia; Male; Mice; Motor Endplate; Muscle Weakness; Neuromuscular Junction Diseases; Physostigmine	2012

Article

Year

Acetylcholinesterase deficiency contributes to neuromuscular junction dysfunction in type 1 diabetic neuropathy.

American journal of physiology. Endocrinology and metabolism, 2012, Aug-15, Volume: 303, Issue:4

Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; GPI-Linked Proteins; Hyperglycemia; Male; Mice; Motor Endplate; Muscle Weakness; Neuromuscular Junction Diseases; Physostigmine

2012